We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Benign Hematology

Journal Scan / Research · June 30, 2020

Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin vs DOACs in Patients With Atrial Fibrillation and ICH

JAMA Network Open

 

Additional Info

JAMA Network Open
Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non–Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage
JAMA Netw Open 2020 Jun 01;3(6)e206424, CT Tsai, JN Liao, CE Chiang, YJ Lin, SL Chang, LW Lo, YF Hu, TC Tuan, FP Chung, TF Chao, GYH Lip, SA Chen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading